{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:30Z","timestamp":1741238670978,"version":"3.38.0"},"reference-count":30,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.nephro.2022.03.008","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T02:25:18Z","timestamp":1665195918000},"page":"634-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9valuation du fer s\u00e9rique comme facteur pr\u00e9dictif d\u2019une r\u00e9ponse de l\u2019h\u00e9moglobine au traitement par fer injectable chez les patients h\u00e9modialys\u00e9s chroniques"],"prefix":"10.1684","volume":"18","author":[{"given":"Clarisse","family":"Gr\u00e8ze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Garrouste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Hadj-Abdelkader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-\u00c9lisabeth","family":"Heng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Aniort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2022.03.008_bib0155","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nephro.2022.03.008_bib0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/nep.12940","article-title":"Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: a systematic review and meta-analysis","volume":"22","author":"Roger","year":"2017","journal-title":"Nephrology."},{"key":"10.1016\/j.nephro.2022.03.008_bib0165","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant."},{"issue":"Suppl\u00a01","key":"10.1016\/j.nephro.2022.03.008_bib0170","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nephro.2022.03.008_bib0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nephro.2015.04.009","article-title":"Use of intravenous iron supplementation in chronic kidney disease: interests, limits, and recommendations for a better practice","volume":"11","author":"Rottembourg","year":"2015","journal-title":"Nephrol Ther."},{"key":"10.1016\/j.nephro.2022.03.008_bib0180","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin","volume":"16","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nephro.2022.03.008_bib0185","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1681\/ASN.V7122654","article-title":"The evaluation of iron status in hemodialysis patients","volume":"7","author":"Fishbane","year":"1996","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nephro.2022.03.008_bib0190","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0272-6386(97)90104-9","article-title":"Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO","volume":"30","author":"Mittman","year":"1997","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nephro.2022.03.008_bib0195","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nephro.2022.03.008_bib0200","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.ki.5002223","article-title":"Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation","volume":"71","author":"Singh","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2022.03.008_bib0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0272-6386(95)90649-5","article-title":"Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era","volume":"26","author":"Kalantar-Zadeh","year":"1995","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nephro.2022.03.008_bib0210","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nephro.2022.03.008_bib0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.1997.323","article-title":"Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients","volume":"52","author":"Fishbane","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2022.03.008_bib0220","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1093\/ndt\/gfq321","article-title":"Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents","volume":"25","author":"Tessitore","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nephro.2022.03.008_bib0225","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ndt\/14.3.659","article-title":"Hypochromic red cells and reticulocyte hemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis","volume":"14","author":"Cullen","year":"1999","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nephro.2022.03.008_bib0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/j.ajkd.2006.02.180","article-title":"Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients","volume":"47","author":"Chen","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nephro.2022.03.008_bib0235","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/ndt\/18.2.370","article-title":"Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients","volume":"18","author":"Chuang","year":"2003","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nephro.2022.03.008_bib0240","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0248-8663(00)00234-4","article-title":"Diagnosis of iron deficiency: evaluation of the \u201csoluble transferrin receptor\/transferrin\u201d ratio","volume":"21","author":"Ruivard","year":"2000","journal-title":"Rev Med Interne."},{"key":"10.1016\/j.nephro.2022.03.008_bib0245","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nephro.2022.03.008_bib0250","doi-asserted-by":"crossref","first-page":"e0132006","DOI":"10.1371\/journal.pone.0132006","article-title":"Reassessment of Iron biomarkers for prediction of dialysis iron overload: an MRI study","volume":"10","author":"Rostoker","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.nephro.2022.03.008_bib0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nep.12735","article-title":"Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis","volume":"22","author":"Holman","year":"2017","journal-title":"Nephrology."},{"key":"10.1016\/j.nephro.2022.03.008_bib0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) controversies conference","volume":"89","author":"Macdougall","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2022.03.008_bib0265","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Dr\u00fceke","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.nephro.2022.03.008_bib0270","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nephro.2022.03.008_bib0275","doi-asserted-by":"crossref","first-page":"e78930","DOI":"10.1371\/journal.pone.0078930","article-title":"Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients","volume":"8","author":"Kshirsagar","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.nephro.2022.03.008_bib0280","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2022.03.008_bib0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.nephro.2022.03.008_bib0290","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice. Recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2022.03.008_bib0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2003.12.029","article-title":"A low serum iron level is a predictor of poor outcome in hemodialysis patients","volume":"43","author":"Kalantar-Zadeh","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nephro.2022.03.008_bib0150","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00467-012-2266-x","article-title":"Association between common iron store markers and hemoglobin in children with chronic kidney disease","volume":"27","author":"Atkinson","year":"2012","journal-title":"Pediatr Nephrol."}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725522001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725522001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2022.03.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:17:49Z","timestamp":1741191469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725522001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1769725522001080"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2022.03.008","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9valuation du fer s\u00e9rique comme facteur pr\u00e9dictif d\u2019une r\u00e9ponse de l\u2019h\u00e9moglobine au traitement par fer injectable chez les patients h\u00e9modialys\u00e9s chroniques","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2022.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}